Archive

Flashes, numbered issues, and beginner references from the Peptide Straight Talk editorial desk.

No Subscription Required

Beginner Glossary

Plain-language definitions of the peptide terms you will see in every issue.

Read the glossary

Survodutide's phase 3 paper is out: what a two-hormone peptide did in type 2 diabetes

Survodutide's phase 3 paper is out: what a two-hormone peptide did in type 2 diabetes

Oct 8, 2026

Peptide Straight Talk · Flash · October 2026 · Educational only, not medical advice

Issue #2 — BPC-157: from a Zagreb lab to everyone's group chat

Issue #2 — BPC-157: from a Zagreb lab to everyone's group chat

Oct 4, 2026

The origin story, what's been studied, and what we're still waiting to learn.

TRIUMPH-2 is in The Lancet: what Retatrutide's 18.8% means

TRIUMPH-2 is in The Lancet: what Retatrutide's 18.8% means

Sep 29, 2026

Peer-reviewed Phase 3 results, plus why July's number was different.

BPC-157 human studies: why people are watching

BPC-157 human studies: why people are watching

Sep 27, 2026

Registry watch — not medical advice.

Why Lilly Is Fighting Over Whether Retatrutide Is a “Biologic”

Why Lilly Is Fighting Over Whether Retatrutide Is a “Biologic”

Sep 24, 2026

Classification is not approval. Argument day is not a ruling.

Issue #1 — Retatrutide: what online stories tell us—and what they leave unanswered

Issue #1 — Retatrutide: what online stories tell us—and what they leave unanswered

Sep 21, 2026

What personal stories can tell us—and what clinical evidence can and cannot establish.

Beginner Glossary, No Subscription Required

Sep 20, 2026